Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
104.5 USD | +1.18% |
|
+3.64% | -15.26% |
07-10 | Jazz Pharmaceuticals plc Promotes Samantha Pearce to Chief Commercial Officer | CI |
07-09 | RBC Trims Price Target on Jazz Pharmaceuticals to $175 From $176, Keeps Outperform Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.26% | 6.52B | |
+63.37% | 856B | |
+38.95% | 631B | |
-4.26% | 359B | |
+17.39% | 325B | |
+8.49% | 297B | |
+5.81% | 234B | |
+16.50% | 226B | |
+15.15% | 177B | |
+2.22% | 165B |
- Stock Market
- Equities
- JAZZ Stock
- News Jazz Pharmaceuticals plc
- Transcript : Codiak Biosciences, Inc., Jazz Pharmaceuticals plc - Special Call